Medicare beneficiaries have experienced a decline in incident heart failure (HF) and a decrease in 1-year HF mortality in recent years; however, the overall burden of HF continues to increase. This according to a study that included a cohort of 2,331,939 unique fee-for-service Medicare beneficiaries (mean age 72 years, 57% women, 86% white, 8% black) followed for all inpatient and outpatient encounters over a 10-year period from 2004 to 2013. Within the cohort, 518,223 patients had preexisting HF, and 349,829 had a new diagnosis of HF during the study period. Further details include:
- The rates of incident HF declined 32%, from 38.7 per 1,000 in 2004 to 26.2 per 1,000 beneficiaries in 2013.
- In contrast, prevalent HF increased during the study period from 162 per 1,000 in 2004 to 172 per 1,000 beneficiaries in 2013.
- Overall 1-year mortality among patients with incident HF was elevated at 24.7%, with a 0.4% absolute decline annually, and a more pronounced decrease among those diagnosed in an inpatient vs outpatient setting.
Khera R, Pandey A, Ayers CR, et al. Contemporary epidemiology of heart failure in fee-for-service Medicare beneficiaries across healthcare settings. [Published online ahead of print November 12, 2017]. Circ Heart Fail. doi:10.1161/CIRCHEARTFAILURE.117.004402.
This Week's Must Reads
HCV Treatment for PWID at Syringe Program, Open Forum Infect Dis; ePub 2018 Mar 6; Eckhardt, et al
Analyzing HCV Treatment in Uninsured Patients, J Community Health; ePub 2018 Mar 6; Sims, et al
To Treat or Not to Treat Acute HCV?, Hepatology; 2018 Mar; Bethea, Chen, et al
Treating Patients with HCV/HIV Coinfection, Hepatology; 2018 Mar; Sikavi, Chen, et al
Liver Stiffness in HCV Patients on Antiviral Therapy, J Gastroenterol Hepatol; ePub 2018 Feb 1; Facciorusso, et al
Must Reads in Cardiology
Intensive BP Treatment & Subsequent CVD Risk, J Am Coll Cardiol; ePub 2018 Mar 7; Phillips, et al
Association of BMI with Lifetime Risk of CVD, JAMA Cardiol; ePub 2018 Feb 28; Khan, et al
Collaborative Care vs Usual Care in Heart Failure, JAMA Intern Med; ePub 2018 Feb 26; Bekelman, et al
Hypertension & Antihypertensive Medication Use, MMWR; 2018 Feb 23; Fang, Gillespie, et al
Aspirin vs Rivaroxaban for VTE Prophylaxis, N Engl J Med; 2018 Feb 22; Anderson, et al